6919-91-1
Chemical Structure
Lauroyl-L-carnitine chloride
- CAS No.: 6919-91-1
- Formula:C19H38ClNO4
- Molecular Weight:379.96
IUPAC Name: (R)-3-carboxy-2-(dodecanoyloxy)-N,N,N-trimethylpropan-1-aminium chloride
InChIKey: PDBBUDRTWRVCFN-UNTBIKODSA-N
SMILES: CCCCCCCCCCCC(O[C@H](CC(O)=O)C[N+](C)(C)C)=O.[Cl-]
Biological Activity: Lauroyl-L-carnitine chloride is an orally active metabolite. Lauroyl-L-carnitine chloride significantly reverses the decrease in its target gene IL-10. Lauroyl-L-carnitine chloride alleviates Crohn' s-like colitis[1].
| Cat. No. | 상품명 | Purity | 제품 설명 | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Lauroyl-L-carnitine chloride | 99.92% | Lauroyl-L-carnitine chloride is an orally active metabolite. Lauroyl-L-carnitine chloride significantly reverses the decrease in its target gene IL-10. Lauroyl-L-carnitine chloride alleviates Crohn' s-like colitis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Lauroyl-L-carnitine-d9 chloride | 98.0% | Lauroyl-L-carnitine-d9 chloride is the deuterium labeled Lauroyl-L-carnitine chloride (HY-130321). Lauroyl-L-carnitine chloride is an orally active metabolite. Lauroyl-L-carnitine chloride significantly reverses the decrease in its target gene IL-10. Lauroyl-L-carnitine chloride alleviates Crohn' s-like colitis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Lauroyl-L-carnitine-d3 hydrochloride | Lauroyl-L-carnitine-d3 (hydrochloride) is a deuterium labeled compound. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Lauroyl-L-carnitine-d3 chloride | 99.95% | Lauroyl-L-carnitine-d3 (chloride) is the deuterium labeled Lauroyl-L-carnitine chloride (HY-130321). Lauroyl-L-carnitine chloride is an orally active metabolite. Lauroyl-L-carnitine chloride significantly reverses the decrease in its target gene IL-10. Lauroyl-L-carnitine chloride alleviates Crohn' s-like colitis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||